Prevalence and Management of Obesity in U.S. Adults With Type 1 Diabetes

LettersMarch 2023Prevalence and Management of Obesity in U.S. Adults With Type 1 DiabetesMichael Fang, PhD, MHS, Yein Jeon, MS, Justin B. Echouffo-Tcheugui, MD, PhD, Elizabeth Selvin, PhD, MPHMichael Fang, PhD, MHSDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MarylandSearch for more papers by this author, Yein Jeon, MSDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MarylandSearch for more papers by this author, Justin B. Echouffo-Tcheugui, MD, PhDDivision of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine, Baltimore, MarylandSearch for more papers by this author, Elizabeth Selvin, PhD, MPHDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MarylandSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M22-3078 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: Survival has significantly improved in patients with type 1 diabetes over the past 2 decades (1), shifting the health profile of this population. Obesity, once a rare condition, now affects up to 37% of U.S. adults with type 1 diabetes (2, 3). However, current studies are based on selected populations and have not considered engagement in lifestyle modification.Objective: To characterize the prevalence and management of overweight and obesity among adults with type 1 diabetes in the general U.S. population.Methods: We analyzed the National Health Interview Survey (NHIS), a nationally representative survey of the noninstitutionalized U.S. population. We ...References1. Ruiz PLD,Chen L, Morton JI, et al. Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts. Diabetologia. 2022;65:964-72. [PMID: 35314870] doi:10.1007/s00125-022-05659-9 CrossrefMedlineGoogle Scholar2. Van der Schueren B, Ellis D, Faradji RN, et al. Obesity in people living with type 1 diabetes. Lancet Diabetes Endocrinol. 2021;9:776-85. [PMID: 34600607] doi:10.1016/S2213-8587(21)00246-1 CrossrefMedlineGoogle Scholar3. Wallace AS, Chang AR, Shin JI, et al. Obesity and chronic kidney disease in US adults with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab. 2022;107:1247-56. [PMID: 35080610] doi:10.1210/clinem/dgab927 CrossrefMedlineGoogle Scholar4. Bullard KM, Cowie CC, Lessem SE, et al. Prevalence of diagnosed diabetes in adults by diabetes type—United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67:359-61. [PMID: 29596402] doi:10.15585/mmwr.mm6712a2 CrossrefMedlineGoogle Scholar5. Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44:2589-2625. [PMID: 34593612] doi:10.2337/dci21-0043 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Michael Fang, PhD, MHS; Yein Jeon, MS; Justin B. Echouffo-Tcheugui, MD, PhD; Elizabeth Selvin, PhD, MPHAffiliations: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MarylandDivision of Endocrinology, Diabetes and Metabolism, Johns Hopkins School of Medicine, Baltimore, MarylandNote: Dr. Fang and Ms. Jeon had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.Grant Support: Dr. Selvin was supported by grant K24 HL152440 from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). Dr. Echouffo-Tcheugui was supported by NIH/NHLBI grant K23 HL153774. The funders had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M22-3078.Reproducible Research Statement: Study protocol: Not available. Statistical code: Available from Dr. Fang (e-mail, mfang9@jhu.edu). Data set: Publicly available at www.cdc.gov/nchs/nhis/2021nhis.htm.Corresponding Author: Michael Fang, PhD, MPH, Johns Hopkins Bloomberg School of Public Health, 2024 East Monument Street, Baltimore, MD 21205; e-mail, mfang9@jhu.edu.This article was published at Annals.org on 14 February 2023. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAchievement of Guideline-Recommended Targets in Diabetes Care in China A Nationwide Cross-Sectional StudyVictor W. Zhong, PhD, Dongmei Yu, PhD, Liyun Zhao, MPH, Yuxiang Yang, MPH, Xiaoguang Li, PhD, Yuge Li, MB, Yue Huang, MPH, Gangqiang Ding, PhD, and Hui Wang, MD, PhD March 2023Volume 176, Issue 3Page: 427-429KeywordsDietExerciseHealth surveysInsulinObesityOverweightPrevention, policy, and public healthType 1 diabetesType 2 diabetesWeight loss ePublished: 14 February 2023 Issue Published: March 2023 Copyright & PermissionsCopyright © 2023 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...